ReviewTranslational andrology and urology2026
Extracellular vesicles in erectile dysfunction: a narrative review of multicellular regulation.
Review in Translational andrology and urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Erectile dysfunction (ED) is a multifactorial disorder involving vascular, neural, smooth muscle, and stromal dysfunction. Currently available treatments only provide symptomatic relief without addressing underlying tissue damage. Extracellular vesicles (EVs) act as mediators of intercellular communication involved in tissue repair. This review aims to summarize current evidence on EVs in ED, with a focus on their roles in multicellular regulation and therapeutic applications. Methods: The PubMed database was reviewed to identify relevant experimental and translational studies on EVs in ED. Studies were included if they focused on EV sources, cargo composition, and their roles in intercellular communication and tissue remodeling. Key Content and Findings: EVs derived from multiple cellular sources, including endothelial cells, smooth muscle cells, fibroblasts, pericytes, and stem/progenitor cells, modulate interconnected processes involving vascular regulation, neurovascular signaling, smooth muscle maintenance, stromal remodeling, fibrosis, and oxidative stress. Preclinical studies consistently demonstrate functional improvement across diabetic, neurogenic, and aging-related ED models through enhancement of angiogenesis, neuroregeneration, anti-apoptotic signaling, and fibrosis modulation. However, therapeutic outcomes vary according to EV origin, cargo composition, isolation methods, and delivery strategies, and current evidence remains largely limited to small animal models without standardized protocols or long-term clinical validation. Conclusions: EVs regulate multicellular communication within the erectile tissue. Despite encouraging preclinical findings, challenges such as heterogeneity, lack of standardization, and limited clinical validation remain. Further advances in precision and mechanism-based EV strategies may help define the therapeutic potential of EV-based approaches in ED.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.